July 11, 2018

Post-Grant for Practitioners: BioPharma Patents at the PTAB

In 2017, 239 IPR petitions relating to biopharma patents were filed-making it the most active year for this technology center. In “BioPharma Patents at the PTAB,” Fish’s Dorothy Whelan and Tasha Francis provide an update on biopharma patents at the PTAB. In it, they discuss PTAB statistics, recent decisions, and the implications of these decisions on the industry and the future impact on biopharma patents.

For a summary of the information presented in this webinar, please see our articles “Orange Book Patent Challenges at the PTAB” and “Establishing Drug Labels as Printed Publications.”

Dorothy Whelan, Principal, Post-Grant Practice Co-Chair
Tasha Francis, Associate
No Comments

Sorry, the comment form is closed at this time.

Fill out the form below to receive our monthly newsletter and updates on your selected areas of interest. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of the email.

  • Fish & Richardson P.C. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the services you requested from us. From time to time, we would like to contact you about our services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.
  • In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
  • You can unsubscribe from these communications at any time. This can be done by clicking the unsubscribe link at the bottom of marketing emails you receive from us, or by emailing stating that you would like to be unsubscribed.
  • This field is for validation purposes and should be left unchanged.